USANA HEALTH SCIENCES, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
USANA HEALTH SCIENCES, INC. (USNA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$8.89 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-11-08
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$2.19M.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-07-01 was -$3.44M.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-04-01 was -$3.26M.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$6.44M.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$31.88M.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$25.12M.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$16.27M.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$21.59M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$5.63M derived: sum of 2 quarters · filed 2017-11-08 | -$8.89M 10-Q · filed 2017-11-08 | -$15.33M derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-07-01 | -$3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$6.70M 10-Q · filed 2017-08-09 | -$13.14M derived: sum of 3 quarters · filed 2017-08-09 | -$25.36M derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-04-01 | -$3.26M 10-Q · filed 2017-05-10 | -$9.70M derived: sum of 2 quarters · filed 2017-05-10 | -$21.92M derived: sum of 3 quarters · filed 2017-11-08 | -$26.22M derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-12-31 | -$6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$18.66M derived: sum of 2 quarters · filed 2017-11-08 | -$22.96M derived: sum of 3 quarters · filed 2017-11-08 | -$31.88M 10-K · filed 2017-03-01 |
| 2016-10-01 | -$12.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$16.52M derived: sum of 2 quarters · filed 2017-11-08 | -$25.44M 10-Q · filed 2017-11-08 | -$32.70M derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-07-02 | -$4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$13.22M 10-Q · filed 2017-08-09 | -$20.48M derived: sum of 3 quarters · filed 2017-08-09 | -$26.99M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-04-02 | -$8.93M 10-Q · filed 2017-05-10 | -$16.18M derived: sum of 2 quarters · filed 2017-05-10 | -$22.69M derived: sum of 3 quarters · filed 2017-05-10 | -$26.66M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-01-02 | -$7.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$13.77M derived: sum of 2 quarters · filed 2017-03-01 | -$17.73M derived: sum of 3 quarters · filed 2017-03-01 | -$25.12M 10-K · filed 2017-03-01 |
| 2015-10-03 | -$6.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$10.48M derived: sum of 2 quarters · filed 2016-11-09 | -$17.86M 10-Q · filed 2016-11-09 | -$26.36M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | -$3.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$11.36M 10-Q · filed 2016-08-09 | -$19.85M derived: sum of 3 quarters · filed 2017-03-01 | -$20.27M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | -$7.39M 10-Q · filed 2016-05-11 | -$15.88M derived: sum of 2 quarters · filed 2017-03-01 | -$16.31M derived: sum of 3 quarters · filed 2017-03-01 | -$25.47M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | -$8.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$8.92M derived: sum of 2 quarters · filed 2017-03-01 | -$18.08M derived: sum of 3 quarters · filed 2017-03-01 | -$16.27M 10-K · filed 2017-03-01 |
| 2014-09-27 | -$426.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$9.59M derived: sum of 2 quarters · filed 2015-11-12 | -$7.78M 10-Q · filed 2015-11-12 | -$19.74M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-28 | -$9.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$7.35M 10-Q · filed 2015-08-12 | -$19.32M derived: sum of 3 quarters · filed 2016-03-01 | |
| 2014-03-29 | $1.81M 10-Q · filed 2015-05-13 | -$10.16M derived: sum of 2 quarters · filed 2016-03-01 | ||
| 2013-12-28 | -$11.97M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | -$21.59M 10-K · filed 2016-03-01 | ||
| 2013-09-28 | -$9.62M 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |